Abstract
Mounting evidence suggests that amyloid-β (Aβ) and vascular etiologies are intertwined in the pathogenesis of Alzheimer’s disease. Spontaneous fluctuations of the brain blood-oxygen-level-dependent (BOLD) signal, as measured by resting-state functional MRI (rs-fMRI), have been shown to be associated with neuronal activities as well as cerebrovascular hemodynamics. Nevertheless, it is unclear if rs-fMRI BOLD fluctuations are associated with brain Aβ deposition in individuals with an elevated risk of Alzheimer’s disease.
We recruited 33 patients with amnestic mild cognitive impairment who underwent rs-fMRI and positron emission tomography (PET). The Aβ standardized uptake value ratio (SUVR) was calculated with cortical white matter as the reference region to improve sensitivity for cortical Aβ quantification. We calculated the amplitudes of low-frequency fluctuations (ALFF) of local BOLD signals in the frequency band of 0.01-0.08 Hz. Applying physiological/vascular signal regression in stepwise increasing levels on the rs-fMRI data, we examined whether local correlations between ALFF and brain Aβ deposition were driven by vascular hemodynamics, spontaneous neuronal activities, or both.
We found that ALFF and Aβ SUVR were negatively correlated in brain regions involving the default-mode and visual networks, with peak correlation at the precuneus, and angular, lingual, and fusiform gyri. Regions with higher ALFF had less Aβ accumulation. The correlated cluster sizes in MNI space were reduced from 3018 mm3 with no physiological/vascular regression to 1072 mm3 with strong physiological/vascular regression, with mean cluster r values at approximately -0.47.
Results demonstrate that both vascular hemodynamics and neuronal activities, as reflected by BOLD fluctuations, are negatively associated with brain Aβ deposition. These findings further imply that local brain blood fluctuations due to either vascular hemodynamics or neuronal activities can affect Aβ homeostasis.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01146717
Funding Statement
Funding towards this work was received from the National Institutes of Health (R01AG033106, R01HL102457, and R01AG057571).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Boards of the University of Texas Southwestern Medical Center and Texas Health Presbyterian Hospital of Dallas and performed by the guidelines of the Declaration of Helsinki and Belmont Report.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The raw data were generated at the University of Texas Southwestern Medical Center and UTSW and Institute for Exercise and Environmental Medicine Texas Health Presbyterian Hospital, Dallas, TX, USA. Derived data supporting the findings of this study are available from the corresponding authors upon reasonable request.
Abbreviations
- ADNI
- Alzheimer’s Disease Neuroimaging Initiative
- AFNI
- Analysis of Functional NeuroImages
- ALFF
- Amplitude of Low-Frequency Fluctuations
- APOE4
- Apolipoprotein E4
- AROMA
- ICA-based Automatic Removal Of Motion Artifacts
- AV45
- 18F-Florbetapir
- Aβ
- Amyloid-β
- BOLD
- Blood-Oxygen-Level-Dependent
- CBF
- Cerebral Blood Flow
- CDR
- Clinical Dementia Rating
- DPABI
- Toolbox for Data Processing & Analysis of Brain Imaging
- DPARSFA
- Data Processing Assistant for Resting-State fMRI advanced edition
- EPI
- Echo Planar Imaging
- FFT
- Fast Fourier Transformation
- flirt
- FMRIB’s Linear Image Registration Tool
- fMRI
- functional MRI
- FMRIB
- Functional Magnetic Resonance Imaging of the Brain
- FSL
- FMRIB Software Library
- FWHM
- Full Width at Half Maximum
- GS
- Global Signal
- ICA
- Independent Component Analysis
- ISF
- Interstitial Fluid
- MELODIC
- Multivariate Exploratory Linear Optimized Decomposition into Independent Components
- MMSE
- Mini-Mental State Examination
- MNI
- Montreal Neurological Institute
- MPRAGE
- Magnetization-Prepared Rapid Acquisition Gradient-Echo
- MRI
- Magnetic Resonance Imaging
- ROC
- Receiver Operating Characteristics
- rs-fMRI
- resting-state fMRI
- sALFF
- standardized ALFF
- SUVR
- Standardized Uptake Value Ratio
- TE
- Time of Echo
- TR
- Time of Repetition
- WM
- White Matter
- WMS-LM
- Wechsler Memory Scale – Revised Logical Memory